DFFN - Diffusion Pharmaceuticals - COVID play for Q3/Q4 2020 | Biotech Swings 👨‍⚕️💉

Maverick 02:11 AM - Jul 21 2020

DFFN - Diffusion Pharmaceuticals - COVID play for Q3/Q4 2020

DFFN

Currently 1.47 (Monday close, +23% from Friday)
60M o/s & float
$19M cash (probably good for another 8 mo)
Dosing to start on COVID trials in July with data in Q3
This is the PR that started this run: https://www.benzinga.com/pressreleases/20/05/g16104691/diffusion-pharmaceuticals-receives-accelerated-fda-response-to-proposed-tsc-covid-19-clinical-tria
Actually sounds sensible: https://www.diffusionpharma.com/product-pipeline/overview-trans-sodium-crocetinate-tsc/

Screen Shot 2020-07-21 at 02.09.33.png 92.08 KB

Comments

Maverick - 3 years ago

Added more here on Friday at 1.30

Maverick - 3 years ago

Looking good here. 1.55 in after hours. Would like to see at least 2.00 on this one.

Maverick - 3 years ago

I added this one twice today, average is 1.33.

I don't expect a straight moonshot up. It'll need some news, which is expected this month (I'd expect them to announce their dosing has started)

Biotech Swings 👨‍⚕️💉

Created By:	Maverick
Created:	Jun 25, 2020
Total Followers:	5
Follow

The strategy here is simple: take 3 to 60 day positions in biotechs that have upcoming catalysts (data readouts, approvals, etc).

Offerings are the major danger, so always be mindful of cash position of the company you're trading.